Mobidiag Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium The company has invested revenues from its pandemic testing business to buy assets that are growing faster than its base business. Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M Hologic intends to invest in assay development for Mobidiag's Novodiag PCR platform, which provides high-level multiplexing to detect infectious disease organisms. Mobidiag SARS-CoV-2, Influenza A/B, RSV Test Receives CE Mark The firm said it is currently also developing Novodiag Resp-4, a molecular test for the rapid, on-demand detection of the viruses. Mobidiag Receives CE Mark for Two PCR SARS-CoV-2 Tests The company already offers an antibody test, Anti-SARS-CoV-2 Rapid Test, that it is distributing for its Chinese joint venture partner Autobio Diagnostics. Mobidiag Gets Finland Emergency Use Authorization for Second Coronavirus Test The Novodiag COVID-19 real-time PCR assay enables on-demand and fully automated detection of early COVID-19 infections in about one hour, the firm said. Apr 14, 2020 Mobidiag Nabs Finland Emergency Use Authorization for Coronavirus Test Feb 12, 2020 Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus Premium Jan 7, 2020 Mobidiag Garners €1.5M for Sepsis MDx Oct 29, 2019 Mobidiag Inks Distribution Agreements in Europe, Middle East for Dx Products Oct 9, 2019 Mobidiag Gets CE Mark for Intestinal Parasites Test Jul 1, 2019 Mobidiag Inks African Distribution Agreement Jun 3, 2019 Mobidiag, Autobio Diagnostics Launch Joint Venture in China May 14, 2019 Mobidiag Secures €25M Loan to Build Test Menu Feb 25, 2019 Mobidiag Inks European, Middle Eastern Distribution Deals Jan 7, 2019 'Superbug' Molecular Test From Mobidiag Gets CE Mark Dec 17, 2018 Mobidiag, Autobio Diagnostics to Form Joint Venture in China Nov 15, 2018 Mobidiag Receives Final €4M Tranche of €15M Financing Project May 29, 2018 Mobidiag Gets Funding for Direct-From-Blood Rapid Sepsis MDx May 24, 2018 Mobidiag Concludes €4M Funding Round Apr 19, 2018 Mobidiag Gets CE Marks for Two Tests Mar 9, 2018 In Brief This Week: Danaher, BGI, Mobidiag, Sygnis Nov 27, 2017 Interlux to Distribute Mobidiag Products in Estonia Jun 26, 2017 Mobidiag Gets CE-IVD Mark for GI Virus Test May 30, 2017 MobiDiag Extends Distribution Agreement With PerkinElmer Apr 18, 2017 Mobidiag Completes €4M Funding Round Load More Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.